Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer
Clinical trial NCT00924287 · TERMINATED
Trial details
- NCT number
- NCT00924287
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-12-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.